Multicenter Study Tracks Long-Term Rituximab Outcomes in Anti-MAG Neuropathy
In a multicenter retrospective study of 149 French patients with anti-MAG neuropathy, 36 percent experienced long-term functional improvement following rituximab ...
Tag: Overall Neuropathy Limitation Scale
POPULAR NEWS
-
ECMO shows promise as rescue therapy for combat casualties, but evidence remains thin
-
MRI habitat radiomics maps tumor diversity to predict lymph node spread in early-stage cervical cancer
-
Japan’s Home Care Use Varies Sharply Across Municipalities Despite Universal Coverage
-
Long Contact Times on AAV Affinity Resins Reshape Yield and Purity